Project Grant R01CA283730
Award Date
5/1/24
Completion Date
4/30/29
Dollars Obligated
$460K
Federal Agency
National Cancer Institute
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
This federal Project Grant award for $995,267 was provided by the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420). The award was granted to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center), a non-profit, National Cancer Institute-designated comprehensive cancer center in Tampa, Florida.
The funding supports a 4-year translational cancer research initiative focused on advancing peer-reviewed cancer...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Treatment Research program (CFDA 93.395), provides $568,538 to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) to investigate how the release of interleukin-1 alpha during various cancer therapies, particularly those inducing necrosis or programmed necrosis, can alter the immune response and create an immunosuppressive tumor environment. The research aims to...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), has awarded a $328,575 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. This 3-year grant, with a start date of September 1, 2024, will support research aimed at "Reversing Exhaustion of Tumor-Infiltrating Lymphocytes for Improvement of Adoptive Cell Therapy." As a National Cancer Institute-designated comprehensive cancer...
The U.S. Department of Defense's Defense Health Agency awarded a $481,749 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will support research to dissect the spatial molecular architecture of the transformed cutaneous T cell lymphoma tumor microenvironment, with the goal of identifying...
This $697,590 federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development program) supports research at the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) to evaluate B-T cell cross-talk within tertiary lymphoid structures in melanoma progression and immune checkpoint blockade. The grant, with a performance period from July 1, 2024 to June 30, 2027, aims to advance scientific understanding of...
This federal Project Grant award, valued at $168,500.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research conducted by the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida, to cotarget Type 1 PRMTS and YAP1 in order to combat EGFR-mutant lung adenocarcinoma. The grant period runs from September 1, 2024 to August 31, 2025. The Moffitt Cancer Center is a nonprofit,...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $2,837,644 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The funding will support "Translational Studies for Targeted Alpha-Particle Therapy for Rare Melanomas" over a 4-year period from September 1, 2023 to August 31, 2027. This project grant aims to advance research into innovative cancer therapies, specifically...
The U.S. Defense Health Agency awarded a $1,619,065 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The grant, awarded on April 15, 2025, supports the "DYNAMIC: Development of a Behavioral Intervention for Young Adults with Advanced Cancer" project, which aims to develop a new behavioral intervention for young adults with advanced cancer. The funding...
This Project Grant award of $1,221,625.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to develop novel genetic mouse models for studying the progression and metastasis of uveal melanoma. The award period runs from June 1, 2024 to May 31, 2027. Moffitt Cancer Center is a prominent National Cancer Institute-designated comprehensive cancer center...
The U.S. Department of Defense's Defense Health Agency has awarded a $762,168 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a project period from September 30, 2023 to September 29, 2026, is intended to "DECONVOLUTE KEY BIOLOGICAL DRIVERS THAT DEFINE SUBSETS OF LETHAL PROSTATE CANCER IN AFRICAN AMERICAN MEN." As a leading National Cancer...